Title page for etd-0730108-171605


[Back to Results | New Search]

URN etd-0730108-171605
Author Chiung-ai Wu
Author's Email Address No Public.
Statistics This thesis had been viewed 5565 times. Download 3212 times.
Department Biological Sciences
Year 2007
Semester 2
Degree Master
Type of Document
Language zh-TW.Big5 Chinese
Title Suppression of Oxidative Stress in the Rostral Ventrolateral Medulla Contributes to Antihypertensive Effect of the Peroxisome Proliferator Activated Receptor Activator Rosiglitazone
Date of Defense 2008-07-21
Page Count 107
Keyword
  • UCP
  • superoxide anion
  • RVLM
  • hypertension
  • PPAR
  • Abstract Peroxisome proliferator activated receptors (PPAR) are members of the nuclear receptor family that act as transcription factors to regulate target gene expression. In addition to their well-known effects in regulation of glucose homeostasis and lipid metabolism, PPAR activators have recently been shown to exert antihypertensive effects, although the underlying mechanism is not clear. Our laboratory has previously demonstrated that oxidative stress of an augmented tissue level of superoxide anion (Ο2•−) in the rostral ventrolateral medulla (RVLM), where promotor neurons for generation of sympathetic vasomotor outflow reside, contributes to neural mechanism of hypertension. I therefore propose to test in my thesis the hypothesis that protection against oxidative stress after activation of the PPARs in the RVLM may contribute to the antihypertensive effect of these transcription factors.
    Experiments were performed in the spontaneously hypertensive rats (SHR) or normotensive Wistar-Kyoto (WKY) rats under anesthesia or conscious condition. Compared to WKY rats, microinjection bilaterally into the RVLM of a synthetic activator of PPARγ, rosiglitazone (1 nmol), evoked significantly greater decreased in mean systemic arterial pressure (MSAP) and heart rate (HR) in SHR. These cardiovascular suppressive
    effects of rosiglitazone were accompanied by greater decrease in tissue level of O2
    - and upregulation of the antioxidant uncoupling proteins (UCPs) in the RVLM of SHR. Rosiglitazone also caused a significant greater increase in PPARγ expression in the nuclear extracts from RVLM of SHR than WKY rats. All these cellular events induced by rosiglitazone were antagonized by co-administration into the RVLM of the PPARγ inhibitor, GW9662 (5 nmol). This PPARγ inhibitor also significantly reversed the cardiovascular depressive effects of rosiglitazone. Together these results suggest that PPARγ in the RVLM may participate in central cardiovascular regulation by promoting hypotension and bradycardia via amelioration of O2- production and upregulation of antioxidant UCPs. Moreover, a downregulation of the PPARγ in the RVLM may contribute to neural mechanism of hypertension.
    Advisory Committee
  • Ming-Hong Tai - chair
  • Samuel H.H. Chan - co-chair
  • Alice Y.W. Chang - advisor
  • Julie Y.H. Chan - advisor
  • Files
  • etd-0730108-171605.pdf
  • indicate accessible in a year
    Date of Submission 2008-07-30

    [Back to Results | New Search]


    Browse | Search All Available ETDs

    If you have more questions or technical problems, please contact eThesys